Acuren [TIC] vs Cintas [CTAS] Detailed Stock Comparison
Acuren
NYSE
Loading...
Cintas
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Acuren wins in 5 metrics, Cintas wins in 11 metrics, with 0 ties. Cintas appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Acuren | Cintas | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 44.48 | 45.02 | Acuren |
| Price-to-Book Ratio | 1.47 | 17.17 | Acuren |
| Debt-to-Equity Ratio | 68.97 | 56.25 | Cintas |
| PEG Ratio | N/A | 5.60 | N/A |
| EV/EBITDA | 42.78 | 30.29 | Cintas |
| Profit Margin (TTM) | -12.62% | 17.54% | Cintas |
| Operating Margin (TTM) | 6.01% | 22.73% | Cintas |
| EBITDA Margin (TTM) | 6.01% | 22.73% | Cintas |
| Return on Equity | -18.02% | 42.19% | Cintas |
| Return on Assets (TTM) | -1.05% | 15.98% | Cintas |
| Free Cash Flow (TTM) | $73.67M | $1.76B | Cintas |
| Dividend Yield | N/A | 0.90% | N/A |
| 1-Year Return | 12.54% | -1.12% | Acuren |
| Price-to-Sales Ratio (TTM) | 2.56 | 7.73 | Acuren |
| Enterprise Value | $3.54B | $84.18B | Cintas |
| EV/Revenue Ratio | 3.18 | 7.97 | Acuren |
| Gross Profit Margin (TTM) | 23.60% | N/A | N/A |
| Revenue per Share (TTM) | $10 | $26 | Cintas |
| Earnings per Share (Diluted) | $-1.25 | $4.50 | Cintas |
| Beta (Stock Volatility) | N/A | 1.00 | N/A |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Acuren vs Cintas Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Acuren | -0.21% | -2.14% | 26.27% | 25.04% | 40.54% | 18.17% |
| Cintas | -0.15% | -0.80% | -1.46% | -7.64% | -1.09% | 11.27% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Acuren | 12.54% | 12.54% | 415.64% | -99.89% | -99.82% | -99.82% |
| Cintas | -1.12% | 103.42% | 138.70% | 802.49% | 2,840.64% | 1,950.71% |
News Based Sentiment: Acuren vs Cintas
Acuren
News based Sentiment: MIXED
October brought a major rebranding for Acuren as it became TIC Solutions following the NV5 merger, but this was tempered by disappointing preliminary Q3 results. The mixed signals – a positive strategic shift alongside weaker financials – create a complex investment picture, making this a significant month for the company.
Cintas
News based Sentiment: MIXED
October 2025 presented a mixed picture for Cintas, with a strong market capitalization and ETF inclusion offset by a 'low' technical rating and intense scrutiny of its upcoming earnings. The month's events highlight both the company's established position and the challenges it faces in maintaining momentum.
Performance & Financial Health Analysis: Acuren vs Cintas
| Metric | TIC | CTAS |
|---|---|---|
| Market Information | ||
| Market Cap | $3.01B | $81.88B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 3,916,990 | 2,119,830 |
| 90 Day Avg. Volume | 3,411,450 | 2,166,837 |
| Last Close | $14.18 | $202.61 |
| 52 Week Range | $8.76 - $14.94 | $180.78 - $229.24 |
| % from 52W High | -5.11% | -11.62% |
| All-Time High | $14,700.00 (Jul 03, 2017) | $229.24 (Jun 06, 2025) |
| % from All-Time High | -99.90% | -11.62% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.02% | 0.09% |
| Quarterly Earnings Growth | N/A | 0.09% |
| Financial Health | ||
| Profit Margin (TTM) | -0.13% | 0.18% |
| Operating Margin (TTM) | 0.06% | 0.23% |
| Return on Equity (TTM) | -0.18% | 0.42% |
| Debt to Equity (MRQ) | 68.97 | 56.25 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $9.63 | $11.80 |
| Cash per Share (MRQ) | $0.65 | $0.34 |
| Operating Cash Flow (TTM) | $58.13M | $2.12B |
| Levered Free Cash Flow (TTM) | $127.12M | $1.49B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.90% |
| Last 12-Month Dividend | N/A | $2.01 |
Valuation & Enterprise Metrics Analysis: Acuren vs Cintas
| Metric | TIC | CTAS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 44.48 | 45.02 |
| Forward P/E | 31.84 | 43.29 |
| PEG Ratio | N/A | 5.60 |
| Price to Sales (TTM) | 2.56 | 7.73 |
| Price to Book (MRQ) | 1.47 | 17.17 |
| Market Capitalization | ||
| Market Capitalization | $3.01B | $81.88B |
| Enterprise Value | $3.54B | $84.18B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.18 | 7.97 |
| Enterprise to EBITDA | 42.78 | 30.29 |
| Risk & Other Metrics | ||
| Beta | N/A | 1.00 |
| Book Value per Share (MRQ) | $9.63 | $11.80 |
Financial Statements Comparison: Acuren vs Cintas
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | TIC | CTAS |
|---|---|---|
| Revenue/Sales | $234.22M | N/A |
| Cost of Goods Sold | $190.55M | N/A |
| Gross Profit | $43.67M | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-8.79M | N/A |
| EBITDA | $20.93M | N/A |
| Pre-Tax Income | $-24.33M | N/A |
| Income Tax | $1.47M | N/A |
| Net Income (Profit) | $-25.79M | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | TIC | CTAS |
|---|---|---|
| Cash & Equivalents | $155.74M | $263.97M |
| Total Current Assets | $376.67M | $3.44B |
| Total Current Liabilities | $107.93M | $1.64B |
| Long-Term Debt | $784.25M | $2.60B |
| Total Shareholders Equity | $1.13B | $4.68B |
| Retained Earnings | $-132.78M | $11.80B |
| Property, Plant & Equipment | $30.52M | $3.50B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | TIC | CTAS |
|---|---|---|
| Operating Cash Flow | $35.09M | $599.12M |
| Capital Expenditures | $-4.18M | $0 |
| Free Cash Flow | $28.32M | $521.13M |
| Debt Repayment | $-4.44M | $-450.00M |
| Common Stock Repurchase | N/A | $-256.67M |
Short Interest & Institutional Ownership Analysis
| Metric | TIC | CTAS |
|---|---|---|
| Shares Short | 7.41M | 7.97M |
| Short Ratio | 4.29 | 4.01 |
| Short % of Float | 0.06% | 0.03% |
| Average Daily Volume (10 Day) | 3,916,990 | 2,119,830 |
| Average Daily Volume (90 Day) | 3,411,450 | 2,166,837 |
| Shares Outstanding | 121.48M | 402.95M |
| Float Shares | 138.35M | 342.95M |
| % Held by Insiders | 0.10% | 0.15% |
| % Held by Institutions | 0.55% | 0.67% |
Dividend Analysis & Yield Comparison: Acuren vs Cintas
| Metric | TIC | CTAS |
|---|---|---|
| Last 12-Month Dividend | N/A | $2.01 |
| Last 12-Month Dividend Yield | N/A | 0.90% |
| 3-Year Avg Annual Dividend | N/A | $1.51 |
| 3-Year Avg Dividend Yield | N/A | 0.22% |
| 3-Year Total Dividends | N/A | $4.53 |
| Ex-Dividend Date | N/A | Aug 15, 2025 |